Evolent Health Revenue, Profits - EVH Quarterly Income Statement

Add to My Stocks
$23.7 $0.3 (1.25%) EVH stock closing price Aug 17, 2018 (Closing)

Fundamental analysis of EVH stock involves analyzing its financial statements, apart from checking the Evolent Health stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from 139.71M to 144.3M and how operating and non operating activities have impacted the EVH stock. Revenue for year 2018 Q2 is $144.3M and has increased from $139.71M quarter on quarter as is evident when you compare the latest figures in the latest Evolent Health profit and loss statement with those of the prior corresponding period. Also see Evolent Health assets and Evolent Health free cash flow for a complete valuation of EVH stock.

View and download details of revenue and profits for Evolent Health for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Evolent Health Revenues or Net Sales
Cost Of Goods Sold (COGS)69M71.97M65.56M68.28M67.99M67.52M59.94M33.9M32.77M28.56M
Evolent Health Gross Profit
Research & Development Expense----------
Selling General & Admin Expense74.23M72.37M55.3M45.93M51.29M53.55M55.37M38.39M32.75M32.09M
Income Before Depreciation Depletion Amortization1.07M-4.63M-7.12M-6.3M-12.21M-14.84M-27.29M-12.09M-9.01M-11.2M
Depreciation Depletion Amortization10.03M9.49M11.14M7.71M6.9M6.61M6.5M3.74M3.61M163.97M
Non Operating Income-0.32M----0.33M-0.33M-0.65M-0.44M-0.01M-
Interest Expense-------0.2M-0.25M-0.27M-
Evolent Health Pretax Income
Provision for Income Taxes-0.11M--4.62M-1.71M-0.7M--9.15M-0.25M-0.37M-0.98M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-10.03M-13.63M-13.61M-12.59M-16.91M-18.01M-17.41M-11.21M-8.39M-122.81M
Extraordinary Items & Discontinued Operations----------
Evolent Health Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS77.21M75.38M74.69M70.33M59.48M52.6M52.18M43.11M42.59M42.19M
Average Shares used to compute Basic EPS77.21M75.38M74.69M70.33M59.48M52.6M52.18M43.11M42.59M42.19M
Income Before Nonrecurring Items-6.03M-2.55M-7.35M-3.17M-8.77M-14.88M-20.66M-11.41M-11.95M-14.16M
Income from Nonrecurring Items-3.89M-11.08M-6.26M-9.42M-8.14M-3.14M3.25M-3.57M-108.66M
Evolent Health Earnings Per Share Basic Net
Evolent Health Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.08-0.03-0.10-0.04-0.13-0.26-0.35-0.26-0.25-0.27
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on Evolent Health stock analysis. An investor must check the following items in an income statement:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $144.3M for this quarter of 2018 Q2. Our Evolent Health revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: Most businesses like Evolent Health try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the EVH income statement, one can check the Evolent Health historical stock prices to check how the price has moved with time.

Evolent Health Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield